Advances in invasive, and particularly noninvasive, methods of CO measurement will allow improved monitoring of the parturient undergoing CD. In the next 5 years, these methods of monitoring CO will undergo further evaluation, validation and application in research and clinical environments. Improved hemodynamic monitoring should allow better understanding, titration and timing of vasopressor and fluid regimens in the parturient undergoing cesarean delivery. Ultimately, this may mitigate some of the hemodynamic variations associated with neuraxial techniques and improve known and unknown maternal and fetal parameters associated with favorable outcomes.
The authors would like to thank Andres Macias of the Brigham and Women's Hospital for his work on this project.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Expert Rev of Obstet Gynecol. 2012;7(1):59-75. © 2012 Expert Reviews Ltd.